SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Marijuana Co of America, Inc. (MCOA) (CIK 0001078799) — Jul 22, 2022

Marijuana Co of America, Inc. (MCOA) (CIK 0001078799)
Date: July 22, 2022 · CIK: 0001078799 · Accession: 0000000000-22-007719

AI Filing Summary & Sentiment

File numbers found in text: 333-266129

Date
July 22, 2022
Author
Not clearly detected
Form
UPLOAD
Company
Marijuana Co of America, Inc. (MCOA) (CIK 0001078799)

Letter

United States securities and exchange commission logo July 22, 2022 Jesus Quintero Chief Executive Officer Marijuana Company of America, Inc. 633 W 5th Street, Suite 2826 Los Angeles, CA 90071 Re:Marijuana Company of America, Inc. Registration Statement on Form S-1 Filed July 14, 2022 File No. 333-266129 Dear Mr. Quintero: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alan T. Hawkins, Esq.

Show Raw Text
United States securities and exchange commission logo
July 22, 2022
Jesus Quintero
Chief Executive Officer
Marijuana Company of America, Inc.
633 W 5th Street, Suite 2826
Los Angeles, CA 90071
Re:Marijuana Company of America, Inc.
Registration Statement on Form S-1
Filed July 14, 2022
File No. 333-266129
Dear Mr. Quintero:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Alan T. Hawkins, Esq.